Press Releases

MCRA hires Bonnie Clothier, PhD, RN, Associate Director, Payor Relations, to Further Expand Reimbursement Payor Relations Service Division

Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA), a leading advisory firm and Clinical Research Organization (CRO) to the medical device in

MCRA Offers Informational Presentation on Medical Device Regulation to the Chinese FDA

The session aimed to collaboratively explore U.S. device regulations and offer high-level knowledge about the FDA review process.

MCRA Assists IlluminOss Medical with Successful De Novo Decision: 1st Orthopedic De Novo Granted by the FDA

WASHINGTON, Jan.

MCRA Assists SANUWAVE with Successful De Novo Decision: 3rd Wound Care De Novo Since 2010

SANUWAVE retained MCRA in January of 2015 to lead interactions and correspondence with the FDA for the dermaPACE.

MCRA Offers Informational Presentation on Medical Device Regulation to the Chinese FDA

NEW YORK, Dec.

MCRA Leads Innovation Training with FDA as Part of its Experiential Learning Program (ELP)

The Experiential Learning Program (ELP) is a learning opportunity designed to help all levels of FDA within the Center for Devices and Radiological

FDA Selects MCRA to Share Expertise as Part of the Experiential Learning Program (ELP)

The Experiential Learning Program (ELP) is a program designed to help all levels of FDA within the Center for Devices and Radiological Health (CDRH

MCRA Releases New White Paper Analyzing the Industry Impact of the Federal Budget Request on FDA

As the medical device market grows due to continued innovation and changing demographics, it is imperative for industry to be able to successfully

MCRA Advises Orthopedic Industry To Adopt Integrated Value Creation Strategy

Mr.

MCRA Expands, Moves to New DC Location

WASHINGTON, Feb.

SANUWAVE Health Submits de novo Petition for FDA Review and Classification of the dermaPACE System to Treat Diabetic Foot Ulcers

ALPHARETTA, Ga., Aug. 11, 2016 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (OTCBB:SNWV) today announced that it has submitted to the U.S.

MCRA Assists Cartiva, Inc. with Obtaining FDA PMA Approval for the Company's Synthetic Cartilage Implant (SCI)

WASHINGTON, July 20, 2016 /PRNewswire-USNewswire/ -- Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the

Learn About Our Unique Approach to Your Challenges

MCRA combines world class know-how and execution in combination with providing your team with a hands-on, proactive, and team-based support at every step of your technology's life cycle.

© MCRA 2018

All Rights Reserved | Terms of Use